Pressure tuning infrared spectroscopic study of cisplatin-induced structural changes in a phosphatidylserine model membrane.
暂无分享,去创建一个
F. Shirazi | P. Wong | K. Taylor | K. D. Taylor | R. Goel | F. H. Shirazi | M. Molepo | P. Popovic | D. J. Stewart | P. T. Wong | D. Stewart | R. Goel | M. Molepo | P. Popović | FH Shirazi | DJ Stewart | PT Wong
[1] D. E. Goldman,et al. Composition and characterization of the lipids of garfish (Lepisosteus osseus) olfactory nerve, a tissue rich in axonal membrane. , 1972, Biochimica et Biophysica Acta.
[2] K. Jacobson,et al. Studies on membrane fusion. III. The role of calcium-induced phase changes. , 1977, Biochimica et biophysica acta.
[3] H. Hauser,et al. Infrared and 31P-NMR studies of the interaction of Mg2+ with phosphatidylserines: effect of hydrocarbon chain unsaturation. , 1989, Biochimica et biophysica acta.
[4] S. Howell,et al. Cellular accumulation of the anticancer agent cisplatin: a review. , 1993, British Journal of Cancer.
[5] J. M. Ritchie,et al. The binding of saxitoxin and tetrodotoxin to excitable tissue. , 1977, Reviews of physiology, biochemistry and pharmacology.
[6] M. Lazdunski,et al. MOLECULAR ASPECTS OF THE STRUCTURE AND MECHANISM OF THE VOLTAGE‐DEPENDENT SODIUM CHANNEL * , 1980, Annals of the New York Academy of Sciences.
[7] L. M. Atkins,et al. Binding of an antitumor platinum compound to cells as influenced by physical factors and pharmacologically active agents. , 1973, Cancer research.
[8] I. Edwards,et al. Distribution of Pt in the urine and kidney of the cisplatin treated rat. , 1986, Toxicology.
[9] H. Hauser,et al. Structure and thermotropic behavior of phosphatidylserine bilayer membranes. , 1982, Biochemistry.
[10] P. Daley-Yates,et al. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin. , 1984, Biochemical pharmacology.
[11] L. Eapen,et al. Cisplatin and radiation in the treatment of tumors of the central nervous system: pharmacological considerations and results of early studies. , 1994, International journal of radiation oncology, biology, physics.
[12] S. Howell,et al. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. , 1988, Cancer research.
[13] A. Leroy. Interactions of platinum metals and their complexes in biological systems. , 1975, Environmental health perspectives.
[14] D. E. Goldman,et al. The polypeptide and the phospholipid components of axon plasma membranes. , 1976, Biochimica et biophysica acta.
[15] S. Howell,et al. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. , 1990, Cancer cells.
[16] J. Kraak,et al. Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromatography with on-line inductively coupled plasma atomic emission spectrometric detection. , 1987, Journal of chromatography.
[17] G. Camejo,et al. Characterization of two different membrane fractions isolated from the first stellar nerves of the squid Dosidicus gigas. , 1969, Biochimica et biophysica acta.
[18] H. Hauser,et al. Infrared studies of fully hydrated saturated phosphatidylserine bilayers. Effect of Li+ and Ca2+. , 1987, Biochemistry.
[19] S. Howell,et al. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. , 1988, Anticancer research.
[20] R. G. Snyder,et al. Vibrational spectra of crystalline n-paraffins: II. Intermolecular effects , 1961 .
[21] I. Edwards,et al. Time course of the binding of platinum to subfractions of the kidney cytosol in the cisplatin-treated rat. , 1986, Research communications in chemical pathology and pharmacology.
[22] Donald A. House,et al. The hydrolysis products of cis-diamminedichloroplatinum(II) 6. A kinetic comparison of the cis- and trans-isomers and other cis-di(amine)di(chloro)platinum(II) compounds , 1991 .
[23] R. Hitzemann,et al. Ethanol-induced changes in neuronal membrane order. An NMR study. , 1986, Biochimica et biophysica acta.
[24] P. Wong. Raman spectroscopy of thermotropic and high-pressure phases of aqueous phospholipid dispersions. , 1984, Annual review of biophysics and bioengineering.
[25] K. Meyer,et al. Cisplatin nephrotoxicity. , 1994, Mineral and electrolyte metabolism.
[26] T. Torkhovskaya,et al. Phospholipid composition of membranes in the tumor cell. , 1970, Biochimica et biophysica acta.
[27] M. Markman,et al. Biochemical modulation of cisplatin toxicity. , 1989, Pharmacology & therapeutics.
[28] H. Mantsch,et al. High-pressure infrared spectroscopic evidence of water binding sites in 1,2-diacyl phospholipids , 1988 .
[29] R. J. Cersosimo,et al. Cisplatin neurotoxicity. , 1989, Cancer treatment reviews.
[30] H. Mantsch,et al. High-pressure infrared study of phosphatidylserine bilayers and their interactions with the local anesthetic tetracaine. , 1990, Biochemistry.
[31] P. Daley-Yates,et al. The inhibition of renal ATPase by cisplatin and some biotransformation products. , 1982, Chemico-biological interactions.
[32] H. Mantsch,et al. Interaction of dipalmitoylphosphatidylcholine and dimyristoylphosphatidylcholine-d54 mixtures with glycophorin. A fourier transform infrared investigation. , 1983, Biochemistry.
[33] Mallinckrodt Chemical Works. Research and Development Progress Report , 1952 .
[34] H. Hauser,et al. Infrared studies of fully hydrated unsaturated phosphatidylserine bilayers. Effect of Li+ and Ca2+. , 1987, Biochemistry.